{"id":"https://openalex.org/W2395037535","doi":"https://doi.org/10.1158/1538-7445.sabcs15-p4-14-13","title":"Abstract P4-14-13: Pertuzumab (P) use in first-line HER2-positive metastatic breast cancer (mBC) in US community oncology practices: Treatment patterns and outcomes","display_name":"Abstract P4-14-13: Pertuzumab (P) use in first-line HER2-positive metastatic breast cancer (mBC) in US community oncology practices: Treatment patterns and outcomes","alternate_titles":[],"publication_year":2016,"publication_date":"2016-02-15","ids":{"openalex":"https://openalex.org/W2395037535","doi":"https://doi.org/10.1158/1538-7445.sabcs15-p4-14-13","mag":"2395037535"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs15-p4-14-13","doi":"https://doi.org/10.1158/1538-7445.sabcs15-p4-14-13","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs15-p4-14-13","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2395037535"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112255499","display_name":"N. J. Robert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N Robert","raw_affiliation_strings":["US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022700409","display_name":"H-P Goertz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H-P Goertz","raw_affiliation_strings":["US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028916394","display_name":"Lina Asmar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L Asmar","raw_affiliation_strings":["US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112129933","display_name":"W-Y Tseng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"W-Y Tseng","raw_affiliation_strings":["US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114166103","display_name":"X. Jiao","orcid":"https://orcid.org/0009-0001-7737-2457","observed_orcids":["https://orcid.org/0009-0001-7737-2457"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"X Jiao","raw_affiliation_strings":["US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082007373","display_name":"Chia C. Portera","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Portera","raw_affiliation_strings":["US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109335995","display_name":"B. Yoo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B Yoo","raw_affiliation_strings":["US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088119887","display_name":"Debra A. Patt","orcid":"https://orcid.org/0000-0001-5185-5170","observed_orcids":["https://orcid.org/0000-0001-5185-5170"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D Patt","raw_affiliation_strings":["US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029418152","display_name":"Vincent Antao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V Antao","raw_affiliation_strings":["US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","Genentech, Inc., South San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Oncology Research Inc., Houston, TX; Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"4_Supplement","first_page":"P4","last_page":"14"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/her2-positive-metastatic-breast-cancer","display_name":"HER2-positive metastatic breast cancer","score":0.9350000023841858},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.9380000233650208},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9279999732971191},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.8880000114440918},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.8610000014305115},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.796999990940094},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6940000057220459},{"id":"https://openalex.org/keywords/community-oncology-practice","display_name":"community oncology practice","score":0.8389999866485596},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.8240000009536743},{"id":"https://openalex.org/keywords/peripheral-neuropathy","display_name":"peripheral neuropathy","score":0.699999988079071},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9150000214576721},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.4560000002384186},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.5580000281333923},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.8759999871253967},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.6970000267028809},{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.5540000200271606},{"id":"https://openalex.org/keywords/de-novo-metastatic-breast-cancer","display_name":"de novo metastatic breast cancer","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8851487636566162},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.7446536421775818},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.7050766944885254},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6787198781967163},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6658637523651123},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.6284403800964355},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.5849677920341492},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5186809301376343},{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.43580561876296997},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4089469313621521},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3896191120147705}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs15-p4-14-13","doi":"https://doi.org/10.1158/1538-7445.sabcs15-p4-14-13","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs15-p4-14-13","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2571310200","https://openalex.org/W2939142118","https://openalex.org/W2416165928","https://openalex.org/W2745807572","https://openalex.org/W2949722600","https://openalex.org/W2602897348","https://openalex.org/W1038342786","https://openalex.org/W4386804037","https://openalex.org/W2621495365","https://openalex.org/W3010153683"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Pertuzumab":[2,322],"was":[3,255],"FDA-approved":[4],"in":[5,9,11,46,48,119,197,257,298,325,332],"6/2012":[6,79],"for":[7,18,36],"use":[8,324],"first-line":[10,47,121,204,295,326],"combination":[12,258],"with":[13,21,38,70,177,190,218,259,287],"trastuzumab":[14],"(H)":[15],"and":[16,34,64,80,82,97,146,169,214,238,261,281,339],"docetaxel":[17],"patients":[19],"(pts)":[20],"HER2-positive":[22,39,71,327],"mBC.":[23],"This":[24,54],"retrospective":[25],"study":[26,55,105],"investigated":[27],"the":[28,91,104,111,120,188,198,203,209,275,288,345],"clinical":[29,101,276],"characteristics,":[30,277],"treatment":[31,279],"patterns,":[32,280],"safety,":[33],"outcomes":[35,244],"pts":[37,113,158,189,211,248,293],"mBC":[40,180,205],"who":[41,73,114],"received":[42,74,115,195,212,216],"a":[43,75,116,139,149,299],"P-containing":[44,76,117,296],"regimen":[45,77,118],"US":[49,333],"community":[50,334],"oncology":[51,335],"practices.":[52],"Methods:":[53],"utilized":[56],"iKnowMed":[57],"electronic":[58],"health":[59],"records,":[60],"Claims":[61],"Data":[62],"Warehouse,":[63],"Social":[65],"Security":[66],"Death":[67],"Index.":[68],"Pts":[69,176],"mBC,":[72,136,192],"between":[78],"6/2014":[81],"were":[83,98,107,124,130,270],"followed":[84],"through":[85],"12/2014,":[86],"had":[87,133,138,148,159,166,171],"\u22652":[88],"visits":[89],"within":[90],"McKesson":[92],"Specialty":[93],"Health/US":[94],"Oncology":[95],"Network,":[96],"not":[99],"on":[100,274],"trials":[102],"during":[103],"period,":[106],"eligible.":[108],"Results:":[109],"Of":[110,187],"322":[112,210,247],"setting,":[122,206],"25%":[123],"\u226565":[125],"years":[126],"of":[127,142,153,157,162,184,208,245,291,344],"age,":[128],"63%":[129],"post-menopausal,":[131],"61%":[132],"hormone":[134],"receptor-positive":[135],"84%":[137],"performance":[140],"status":[141],"0":[143],"or":[144,173],"1,":[145],"76%":[147],"Charlson":[150],"Comorbidities":[151],"Index":[152],"0.":[154],"Twenty-one":[155],"percent":[156],"1":[160],"site":[161],"metastasis":[163],"noted,":[164],"32%":[165],"2":[167],"sites,":[168],"47%":[170],"3":[172],"more":[174],"sites.":[175],"de":[178],"novo":[179],"made":[181],"up":[182],"40%":[183],"this":[185],"cohort.":[186],"recurrent":[191],"over":[193],"60%":[194],"H":[196,260],"early-stage":[199],"BC":[200],"setting.":[201,301],"In":[202],"93%":[207],"H+P+taxane,":[213],"7%":[215],"H+P":[217],"other":[219],"chemotherapy":[220,262],"agent(s).":[221],"Common":[222],"adverse":[223],"events":[224],"reported":[225],"included:":[226],"fatigue":[227],"(49%),":[228],"diarrhea":[229],"(44%),":[230],"nausea":[231],"(33%),":[232,235],"peripheral":[233],"neuropathy":[234],"neutropenia":[236],"(24%),":[237],"rash":[239],"(22%).":[240],"Further":[241],"analyses":[242],"including":[243],"these":[246,292],"will":[249,283],"be":[250,284],"presented.":[251],"Conclusions:":[252],"First-line":[253],"P":[254],"given":[256],"agent(s)":[263],"(93%":[264],"taxane).":[265],"No":[266],"new":[267],"safety":[268,282],"signals":[269],"observed.":[271],"More":[272],"details":[273],"specific":[278],"presented,":[285],"along":[286],"progression-free":[289],"survival":[290],"receiving":[294],"therapy":[297],"real-world":[300],"Citation":[302],"Format:":[303],"Robert":[304],"N,":[305],"Goertz":[306],"H-P,":[307],"Asmar":[308],"L,":[309],"Tseng":[310],"W-Y,":[311],"Jiao":[312],"X,":[313],"Portera":[314],"C,":[315],"Yoo":[316],"B,":[317],"Patt":[318],"D,":[319],"Antao":[320],"V.":[321],"(P)":[323],"metastatic":[328],"breast":[329],"cancer":[330],"(mBC)":[331],"practices:":[336],"Treatment":[337],"patterns":[338],"outcomes.":[340],"[abstract].":[341],"In:":[342],"Proceedings":[343],"Thirty-Eighth":[346],"Annual":[347],"CTRC-AACR":[348],"San":[349,357],"Antonio":[350],"Breast":[351],"Cancer":[352,363],"Symposium:":[353],"2015":[354],"Dec":[355],"8-12;":[356],"Antonio,":[358],"TX.":[359],"Philadelphia":[360],"(PA):":[361],"AACR;":[362],"Res":[364],"2016;76(4":[365],"Suppl):Abstract":[366],"nr":[367],"P4-14-13.":[368]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2395037535","counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2016-06-24T00:00:00"}
